iiinova — where your digital self keeps evolving

Josep Carreras Leukaemia Research Institute @carrerasijc.bsky.social · 29/09/2026

🧬 Exploring the potential of spatial biology! #ESSB2026 brings together over 700 experts to share the latest advances in the field. Our researcher Eduard Porta co-organises the conference alongside @cnag-eu.bsky.social, @ibecbarcelona.eu, @lji.org & IJC. 🔗 www.carrerasresearch.org/en/news/euro...

012

Josep Carreras Leukaemia Research Institute @carrerasijc.bsky.social · 25/09/2026

IJC took part in #SOMMaConnect2026 (@sommalliance.bsky.social), bringing together centres of research excellence, companies, investors and the innovation community. Building connections to accelerate knowledge transfer and advance blood cancer research. 🔗 www.carrerasresearch.org/en/news/the-...

000

Josep Carreras Leukaemia Research Institute @carrerasijc.bsky.social · 22/09/2026

🏛️ La Dra. Anna Bigas, jefa de grupo en el IJC y el @researchmar.bsky.social, se incorpora al patronato de @contracancerinv.bsky.social. Contribuirá a apoyar una investigación oncológica de calidad y a que sus avances lleguen antes a los pacientes. 🔗 www.carrerasresearch.org/es/noticias/...

032

Josep Carreras Leukaemia Research Institute @carrerasijc.bsky.social · 21/09/2026

🤝 Neix el Consorci Oncològic Integral Nord Catalunya, una aliança que uneix assistència, recerca, docència i innovació. Donarà cobertura a prop de 2 milions de persones i aspira a obtenir la certificació europea com a Comprehensive Cancer Consortium. 🔗 www.carrerasresearch.org/ca/noticies/...

000

Josep Carreras Leukaemia Research Institute @carrerasijc.bsky.social · 18/09/2026

🔎 We're looking for a Doctoral Candidate! Join the @marcusbuschbeck.bsky.social through the @capathfinders.bsky.social programme and work on new treatment approaches for Blood Cancers MPN. 🔗 Apply until 14 Oct 👇 careers.carrerasresearch.org/jobs/8361127... #JobOffer

000

Josep Carreras Leukaemia Research Institute @carrerasijc.bsky.social · 08/09/2026

🧬 How is immunology shaping the future of blood cancer treatment? Join us at the IJC Symposium 2026, 5–6 Nov, exploring "Immunity in Haematological Malignancies: From Molecular Mechanisms to Transformative Therapies". 📢 Submit your abstract by 18 Sept. 🔗 www.carrerasresearch.org/en/p/immunit...

000

Josep Carreras Leukaemia Research Institute @carrerasijc.bsky.social · 07/09/2026

The ESPACE atlas led by Dr @elimereu.bsky.social group (IJC) shows that some pancreatic cells can adopt transitional states between different cell identities. 🔗 Read the study published in Cell Metabolism: www.cell.com/cell-metabol...

121

Josep Carreras Leukaemia Research Institute @carrerasijc.bsky.social · 04/09/2026

Today, on #WorldLeukaemiaDay, we reaffirm our mission to eradicate blood cancers. For every patient and every family affected by these diseases, we keep pushing science forward🔬 Together, we are unstoppable 💪

000

Josep Carreras Leukaemia Research Institute @carrerasijc.bsky.social · 02/09/2026

The Josep Carreras Institute has joined #BLOODPAC, an international consortium working to advance liquid biopsy research and its clinical implementation. 🔗 Find out more: www.carrerasresearch.org/en/news/the-...

000

Reposted by Josep Carreras Leukaemia Research Institute

CNAG @cnag-eu.bsky.social · 21/08/2026

🚨Don't miss one of the leading events in Spatial Biology! 3rd Conference of the European Society for Spatial Biology 🗓️September 28 – October 1, 2026 📍Sitges (Spain) With the support of CNAG, @ibecbarcelona.eu, @carrerasijc.bsky.social & @lji.org spatialbiologysociety.eu #SpatialBiology #ESSB2026

033

Josep Carreras Leukaemia Research Institute @carrerasijc.bsky.social · 26/08/2026

🧬 Inherited genetic variants can help identify patients at higher risk of aggressive therapy-related blood cancers, according to a new study led by Dr @kikosole.bsky.social and published in Blood Advances. 🔗 www.carrerasresearch.org/en/news/inhe...

000

Josep Carreras Leukaemia Research Institute @carrerasijc.bsky.social · 14/07/2026

🧬 Researchers have uncovered a new therapeutic vulnerability in one of the most aggressive childhood leukaemias. The preclinical study, published in Blood, was led by the Josep Carreras Institute, GENyO, University of Granada and IRSJD. 🔗 www.carrerasresearch.org/en/news/stud...

000

Josep Carreras Leukaemia Research Institute @carrerasijc.bsky.social · 10/07/2026

📢 Registration is now open for the IJC Symposium 2026! Join us on 5–6 Nov in Barcelona to explore the latest advances in the immunology of haematological malignancies and future therapies for blood cancers. 🧬 Free registration 📄 Abstract submissions open 🔗 carrerasresearch.org/en/p/immunit...

000

Josep Carreras Leukaemia Research Institute @carrerasijc.bsky.social · 20/02/2026

👩‍🔬 ¿Las claves de una carrera científica de éxito? “Un buen equipo y esforzarse en conseguir la excelencia”, Dra. @bmjavierre.bsky.social . @raciencias.bsky.social y Mastercard reconocen a la Dra. Javierre en su 🏅 #PremioMujerYCiencia. 🔗 www.carrerasresearch.org/es/noticias/...

020

Josep Carreras Leukaemia Research Institute @carrerasijc.bsky.social · 29/01/2026

The @achilles-dn.bsky.social, coordinated by Dr Laura Belver, brings together 15 centres in 12 countries to train PhD researchers in experimental haemato-oncology and accelerate translational blood cancer research. 🔗 Learn more: www.carrerasresearch.org/en/news/the-...

122

Josep Carreras Leukaemia Research Institute @carrerasijc.bsky.social · 22/01/2026

📢 Join us on Monday 9 Feb 2026 for a high-level symposium on Follicular Lymphoma! The symposium will bring together leading experts to share discoveries and drive projects that improve treatments and quality of life of patients with FL. 👉 Register in-person or online: forms.office.com/e/Cqix1YVB8b

000

Josep Carreras Leukaemia Research Institute @carrerasijc.bsky.social · 15/01/2026

Un placer recibir la visita de CRIS contra el Cáncer en el IJC. Intercambiamos visiones, compartimos nuestro plan estratégico e iniciativas clave y exploramos cómo unir fuerzas para acelerar el impacto frente a los cánceres de la sangre 🔬 🤝

000

Josep Carreras Leukaemia Research Institute @carrerasijc.bsky.social · 12/01/2026

🔬 Dr Alex Vaquero (@vaquerolab.bsky.social) will study the restoration of PAX5 balance in leukemic cells as a new tool in the fight against B-ALL thanks to the support from @caixaresearch.bsky.social 🙌 Know more about their project 👇 www.carrerasresearch.org/en/news/rest...

111

Josep Carreras Leukaemia Research Institute @carrerasijc.bsky.social · 24/10/2025

¿Qué avances científicos nos esperan en el ámbito del envejecimiento? No te pierdas la mesa redonda “El reto de hacerse mayor” para descubrir cómo la ciencia está cambiando nuestra forma de envejecer. 📅 6 Nov, 18:30 📍 Auditorio @the_prbb BCN 🎟️ Entrada libre 👩‍🔬Moderado por @vrodillab.bsky.social

132

Josep Carreras Leukaemia Research Institute @carrerasijc.bsky.social · 23/10/2025

The Josep Carreras Institute made its mark at #BIOSPAIN2025! Our team fostered key collaborations 🤝, shared new leadership initiatives 💡and reinforced IJC’s position as a leading centre in #BloodCancer research 🔬 🔗 www.carrerasresearch.org/en/news/the-...

020

Josep Carreras Leukaemia Research Institute @carrerasijc.bsky.social · 22/10/2025

We’re proud to host the 2nd @securedproject.bsky.social Demonstration Workshop at IJC on 3-4 December! A unique opportunity for research, healthcare and cybersecurity experts to explore cutting-edge solutions for secure biomedical data processing. Register here!🔗 secured-project.eu/2nd-demo-wor...

031

Reposted by Josep Carreras Leukaemia Research Institute

Chromatin Biology Lab @vaquerolab.bsky.social · 04/10/2025

🚨 We are hiring! A #Postdoc position is open in the Chromatin Biology Lab to work on Sirtuins & Leukemia 🧬 If you are up to the challenge join our @vaquerolab.bsky.social team at @CarrerasIJC.bsky.social Apply here 👉 careers.carrerasresearch.org/jobs/6549033-v… Sirtuins rule! 🦾

careers.carrerasresearch.org

VAC_82_2025 - POSTDOCTORAL RESEARCHER (Chromatin biology laboratory) - Institut de Recerca contra la Leucèmia Josep Carreras

Join the Josep Carreras Leukaemia Research Institute and contribute to our mission of innovating and advancing the fight against leukaemia and other hematologic diseases.

032

Reposted by Josep Carreras Leukaemia Research Institute

IDIBAPS @idibaps.bsky.social · 25/09/2025

IDIBAPS SEMINAR Malignant transformation of the immune system and therapeutic solutions 📆6/10 15h 👨‍🔬Ari Melnick, @carrerasijc.bsky.social 📍 Esteve Auditorium, CEK 👉https://f.mtr.cool/earftanszd

001

Josep Carreras Leukaemia Research Institute @carrerasijc.bsky.social · 25/07/2025

Our common goal: curing childhood leukaemia 🤝 The Josep Carreras Institute, the Josep Carreras Foundation and the Sant Joan de Déu Research Institute launch a joint programme to advance research into paediatric blood cancers 🔬 🔗 Read more: www.carrerasresearch.org/en/news/new-...

031

Josep Carreras Leukaemia Research Institute @carrerasijc.bsky.social · 23/07/2025

📢 La unidad de Comunicación del IJC ha sido acreditada como Unidad de Cultura Científica y de la Innovación (UCC+I) por #FECYT. Un paso clave para seguir acercando la ciencia a la sociedad🔬 🔗 www.carrerasresearch.org/es/noticias/...

010

Josep Carreras Leukaemia Research Institute @carrerasijc.bsky.social · 21/07/2025

La Dra. Sònia Guil nos habla de su investigación en #SíndromeDeRett y del nuevo fármaco que están desarrollando con el objetivo de revertir sus síntomas. No te pierdas su entrevista en 'A golpe de bit' en #RNE 📻 Escúchala aquí 👇 www.rtve.es/play/audios/...

rtve.es

QTX153, el fármaco español contra el Síndrome de Rett

El Síndrome de Rett es un trastorno genético neurológico poco frecuente que afecta a la forma en la que se desarrolla el cerebro.

000

Josep Carreras Leukaemia Research Institute @carrerasijc.bsky.social · 18/07/2025

Congratulations, Dr Obiols! 👩‍🔬 Mireia Obiols, researcher at the @jlsardinalab.bsky.social, has successfully defended her #PhD thesis today at the IJC Auditorium. Proud of your dedication and hard work 💪

011

Josep Carreras Leukaemia Research Institute @carrerasijc.bsky.social · 17/07/2025

🚨New research by @jlsardinalab.bsky.social and Gemma Valcarcel published at Science Advances uses a CRISPR technology to control immune cell response to inflammation in the lab. 🔗 Read more: www.carrerasresearch.org/en/news/epig...

030

Josep Carreras Leukaemia Research Institute @carrerasijc.bsky.social · 16/07/2025

Last #YoungResearchers Seminars before the summer break! 👩‍🔬 Our talented researchers Mar Gusi (Maribel Parra's lab) and Alba Vidal (Anna Bigas' lab) gave excellent presentations yesterday, sharing their work to the rest of the IJC community. We’ll be back in September with more inspiring seminars✨

020

Josep Carreras Leukaemia Research Institute @carrerasijc.bsky.social · 10/07/2025

📢 Registration open! Explore the latest advances in cellular #senescence at the upcoming International Conference of @senescel.org 🧬 📅 06-07 November 2025 📍 Barcelona More information ⬇️ senescel2025.senescel.org Co-organised by IJC Group Leader Dr. Verónica Rodilla ‪@vrodillab.bsky.social‬

043

Josep Carreras Leukaemia Research Institute @carrerasijc.bsky.social · 08/07/2025

🧬 New research from Pablo Menéndez's lab presents a novel CAR-T cells therapy designed to target 2️⃣ specific markers of T-ALL: the CD1a and CCR9 proteins. Preclinical results show high efficacy and safety in the lab. 🔗 carrerasresearch.org/en/news/a-ne... 🤝 ISS Aragon, OneChain Immunotherapeutics

010

Josep Carreras Leukaemia Research Institute @carrerasijc.bsky.social · 22/05/2025

El Dr. @manelesteller.bsky.social , de l’IJC, i el Dr. @macips01.bsky.social reben el premi Jaume Aiguader i Miró de l'Acadèmia de Ciències Mèdiques i de la Salut per “El secret de la vida eterna” 📖 🔗 www.carrerasresearch.org/ca/noticies/...

051

Josep Carreras Leukaemia Research Institute @carrerasijc.bsky.social · 21/05/2025

💬🔬 Yesterday we held another inspiring Group Leaders Seminar at the Josep Carreras Institute Dr Tomàs Navarro and Dr Gaël Roué shared deep insights into the biology and treatment of B-Lymphomas 👏 Sharing science is key to moving forward together 🚀

030

Josep Carreras Leukaemia Research Institute @carrerasijc.bsky.social · 20/05/2025

This Friday, do not miss Dr Rouault-Pierre's Invited Lecture! 💬 "Metabolic intervention in Myelodysplastic Neoplasm; Endoplasmic Reticulum Stress governs a splicing programme in healthy and malignant cells" 🗓️ 23 May, 12pm CEST 📍IJC Auditorium Online at 👉 us06web.zoom.us/webinar/regi...

063

Josep Carreras Leukaemia Research Institute @carrerasijc.bsky.social · 20/05/2025

🔬🌍 Today, on #ClinicalTrialsDay, we celebrate the power of research to save lives A hopeful milestone: In a phase I clinical trial, our new CAR-T therapy has shown promising results in patients with a highly resistant lymphoma 📄 Read the full story: www.carrerasresearch.org/en/news/new-...

040

Josep Carreras Leukaemia Research Institute @carrerasijc.bsky.social · 14/05/2025

Yesteday we officially welcomed Dr Ari Melnick, the new Director of the Josep Carreras Institute. 💬 "I see us as a team united in our purpose to eradicate blood cancers." He reaffirmed his commitment to scientific progress and collaborative growth in front of #IJC community 🚀

040

Josep Carreras Leukaemia Research Institute @carrerasijc.bsky.social · 14/05/2025

New study co-led by @manelesteller.bsky.social shows that epigenetic profiling identifies two distinct subtypes of Burkitt lymphoma, allowing early prediction of disease aggressiveness. This could help tailor treatment strategies from diagnosis. 🧬📈 👉 www.carrerasresearch.org/en/news/epig...

carrerasresearch.org

Epigenetics predicts the aggressiveness of Burkitt Lymphoma, a common paediatric tumour in developing countries

Researchers of the Cancer Epigenetics group at the Josep Carreras Leukaemia Research Institute have discovered that patients with Burkitt lymphoma — a common...

000

Josep Carreras Leukaemia Research Institute @carrerasijc.bsky.social · 05/05/2025

❗️🔬 New research from @scuartero.bsky.social's lab reveals that CEBPA mutations in #AML increase resistance to inflammation but make cells more vulnerable to protein-folding stress, opening the door to new treatment strategies. ➡️ www.carrerasresearch.org/en/news/a-co...

050

Josep Carreras Leukaemia Research Institute @carrerasijc.bsky.social · 29/04/2025

New CD30-targeted CAR-T therapy shows 100% overall response and 50% complete remission in Refractory Hodgkin Lymphoma patients 👉 carrerasresearch.org/en/news/new-... 🔬 Led by Dr. Javier Briones, PI at #IJC and @irsantpau.bsky.social @hospitalsantpau.bsky.social 📝 @bloodjournal.bsky.social

020

Josep Carreras Leukaemia Research Institute @carrerasijc.bsky.social · 22/04/2025

We're pleased to announce that Dr Ari Melnick has been appointed new Director of the Josep Carreras Institute. Dr Melnick will lead IJC in our mission to advance #research in #leukaemia and other malignant blood diseases. Read the full release here: www.carrerasresearch.org/en/news/dr-a...

0136

Josep Carreras Leukaemia Research Institute @carrerasijc.bsky.social · 15/04/2025

🧬 Genetic susceptibility to cancer explained. New study by Eduard Porta's lab at @cellpress.bsky.social describes 119 germline variants with significant contribution to cancer onset and progession. ➡️ carrerasresearch.org/en/news/new-...

040

Josep Carreras Leukaemia Research Institute @carrerasijc.bsky.social · 14/04/2025

Next week, we’re honoured to welcome to IJC Dr. Rainer Storb, a world-leading expert in haematology. "History of Allogeneic Hematopoietic Cell Transplantation as an Example of Intensive Bench-to-Bedside Research" 🗓️ 24 April - 12pm 📍 IJC Auditorium +Online 🔗 www.carrerasresearch.org/en/events/hi...

020

Josep Carreras Leukaemia Research Institute @carrerasijc.bsky.social · 11/04/2025

La Dra. @bmjavierre.bsky.social ha sido reconocida con el prestigioso Premio CRIS Excelencia de #CRISContraElCáncerr 🏆 Gracias al programa, su grupo estudiará cómo el ADN 🧬se ve alterado en el tratamiento de la leucemia linfoblástica de células B y cómo esto puede llevar a recaídas.

030

Josep Carreras Leukaemia Research Institute @carrerasijc.bsky.social · 11/04/2025

The #SingleCell Unit (SCU) provides state-of-the-art genomic & transcriptomic analysis at single-cell resolution. We help researchers uncover the full heterogeneity of complex diseases like blood cancers. www.carrerasresearch.org/en/units/sin...

121

Josep Carreras Leukaemia Research Institute @carrerasijc.bsky.social · 10/04/2025

At IJC, we’re committed to promoting healthy habits in the workplace 🥦🍎🏃‍♂️ Thanks to #FundacióAlicia, our team has had the opportunity to gain practical insights on nutrition to support a healthier and more balanced lifestyle.

010

Josep Carreras Leukaemia Research Institute @carrerasijc.bsky.social · 09/04/2025

🚀 Empowering researchers accelerates science! 🧬💻Our #Bioinformatics Unit runs frequent training sessions, such as last weeks' #R for programming & data visualization, or this weeks' High Performance Computing (#HPC) for big data analysis Learn more👉 ijcbit.eu/training/

020

Josep Carreras Leukaemia Research Institute @carrerasijc.bsky.social · 08/04/2025

📣 On today's Young Researchers Seminars, Barbara Chalhoub 👩‍🔬 (Laura Mondragón's lab) discussed APAF-1 deficiency in tumor progression, while Víctor Sánchez 👨‍🔬 (@manelesteller.bsky.social) shared insights on novel treatments to enhance cancer immunotherapy 🧪🧫 Well done, young researchers!✨🔬

000

Josep Carreras Leukaemia Research Institute @carrerasijc.bsky.social · 08/04/2025

#DíaMundialDeLaSalud la Unidad de Innovación trabaja para que la investigación se transforme en soluciones reales para los pacientes Trazan la mejor estrategia para transformar la investigación en soluciones tangibles para la sociedad. ✨Innovar es convertir ideas en impacto

010

Josep Carreras Leukaemia Research Institute @carrerasijc.bsky.social · 07/04/2025

El Instituto Josep Carreras recibe la Acreditación Centros de @contracancerinv.bsky.social, un reconocimiento a la excelencia científica 🔬 y calidad en la gestión institucional ✨ 👉 carrerasresearch.org/es/noticias/...

000

Josep Carreras Leukaemia Research Institute @carrerasijc.bsky.social · 04/04/2025

🧬 New insights into #MDS & #TP53! 🔬 New study with the participation of @kikosole.bsky.social identified a subset of MDS patients with non-mutational p53 dysfunction, showing a distinct immunosuppressive profile, which may be one of the drivers of their poor prognosis.

021